Biogen Inc. (BIIB) on Decifer

Why it ranks here

• Sales are growing about 2% a year, faster than 7 in 100 companies we measure.
• It keeps about 21 cents of every sales dollar as cash, safer than 84 in 100 companies we measure.
• It earns about 7% a year on the money put into the business, better than 40 in 100 companies we measure.
• It costs about 45 times its yearly profit; the middle of its industry is 42. Cheaper than 40 in 100 companies we measure, against their own industries.

The current read

The evidence on BIIB lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Read the full BIIB research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.